Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/PHARMAESSENTIA-CORPORATIO-26902371/actualite/PharmaEssentia-Corporation-met-a-jour-la-demande-de-DNR-de-l-essai-clinique-de-phase-I-du-traitemen-46100638/?utm_source=whatsapp&utm_medium=social&utm_campaign=share